Compare BMY & BMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMY | BMO |
|---|---|---|
| Founded | 1887 | 1817 |
| Country | United States | Canada |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 93.6B |
| IPO Year | N/A | N/A |
| Metric | BMY | BMO |
|---|---|---|
| Price | $58.92 | $138.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 1 |
| Target Price | $61.93 | ★ $163.00 |
| AVG Volume (30 Days) | ★ 9.9M | 663.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.20% | 3.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.28 |
| Revenue Next Year | N/A | $4.45 |
| P/E Ratio | ★ $17.26 | $17.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $85.40 |
| 52 Week High | $62.89 | $149.01 |
| Indicator | BMY | BMO |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 43.71 |
| Support Level | $46.16 | $136.90 |
| Resistance Level | $62.47 | $147.68 |
| Average True Range (ATR) | 1.13 | 3.07 |
| MACD | -0.46 | -0.89 |
| Stochastic Oscillator | 18.29 | 2.42 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Bank of Montreal is a diversified financial-services provider based in North America with over CAD 1.4 trillion in assets. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.